Viewing Study NCT00866333


Ignite Creation Date: 2025-12-25 @ 2:42 AM
Ignite Modification Date: 2026-03-03 @ 4:14 AM
Study NCT ID: NCT00866333
Status: TERMINATED
Last Update Posted: 2019-10-22
First Post: 2009-03-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 2 Multi-Center Study of Entinostat (SNDX-275) in Patient With Relapsed or Refractory Hodgkin's Lymphoma
Sponsor:
Organization: